Sri Lanka
Showing 1 - 25 of 201
Comparative Metabolomics in Diabetes Patients From Sri Lanka and
Terminated
- Diabetes Mellitus, Type 2
- Clinical examination
- +2 more
-
Bern, SwitzerlandUniversity Hospital Inselspital, Berne
Mar 14, 2023
Arbovirus Infections Trial in Colombo, Ragama (Transfluthrin, Placebo)
Not yet recruiting
- Arbovirus Infections
- Transfluthrin
- Placebo
-
Colombo, West, Sri Lanka
- +1 more
Jul 6, 2022
SARS-CoV-2 Infection Trial in Canada, Sri Lanka (Nitric Oxide, Nasal spray with isotonic saline)
Active, not recruiting
- SARS-CoV-2 Infection
- Nitric Oxide
- Nasal spray with isotonic saline
-
Oshawa, Ontario, Canada
- +5 more
Nov 3, 2022
Hypertension Trial in Worldwide (Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5
Recruiting
- Hypertension
- Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
- +7 more
-
Phoenix, Arizona
- +84 more
Aug 19, 2022
Engagement, Positive Parenting, Child Maltreatment Trial in Putrajaya (ParentText)
Recruiting
- Engagement
- +3 more
- ParentText
-
Putrajaya, Putraja, MalaysiaFamily and Child Ecology at the Department of Human Development
Jun 22, 2022
Investigate Transmission and Burden of PVL-MRSA in Households in
Not yet recruiting
- Staphylococcus Aureus
- (no location specified)
May 12, 2021
Biomarker for Cystic Fibrosis
Active, not recruiting
- Chronic Nasal Congestion
- +6 more
-
Tirana, Albania
- +4 more
Mar 23, 2022
Biomarker for Alport Syndrome (BioAlport)
Active, not recruiting
- Nephritis, Hereditary
- Hematuria-Nephropathy-Deafness Syndrome
-
Tirana, Albania
- +6 more
Mar 23, 2022
Assessing Exclusive Breastfeeding Practice
Completed
- Exclusive Breastfeeding
- +2 more
- Deuterium dose-to-mother method for assessing breastfeeding
- (no location specified)
Jul 23, 2023
Intracerebral Haemorrhage (ICH), Hypertension Trial in Worldwide (telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg,
Recruiting
- Intracerebral Haemorrhage (ICH)
- Hypertension
- telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg
- Placebo
-
Bruce, Australian Capital Territory, Australia
- +64 more
Aug 25, 2021
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)
Active, not recruiting
- Hypomelanotic Macules
- +8 more
-
Tirana, Albania
- +7 more
Mar 23, 2022
Biomarkers for Inborn Errors of Metabolism
Completed
- Inborn Errors of Metabolism
- Biomarker
-
Tirana, Albania
- +12 more
Mar 23, 2022
Biomarker for Duchenne Muscular Dystrophy
Completed
- Increased Lordosis/Scoliosis
- +7 more
-
Tirana, Albania
- +11 more
Mar 23, 2022
Lymphedema, Lymphatic Filariasis, Filariasis Trial in Galle (Doxycycline, Placebo)
Completed
- Lymphedema
- +2 more
- Doxycycline
- Placebo
-
Galle, Southern Province, Sri LankaUniversity of Ruhuna
Mar 16, 2021
Biomarker for Hypophosphatasia Disease (BioHypophos)
Active, not recruiting
- Defective Mineralization
-
Rostock, Germany
- +2 more
May 12, 2021
Biomarker for Mannosidosis Disease (BioMannosidosis)
Active, not recruiting
- Alpha-Mannosidase B Deficiency
- +2 more
-
Rostock, Germany
- +2 more
May 12, 2021
Gestational Diabetes in Pregnancy Trial in Bangladesh, India, Sri Lanka (Life style Intervention)
Completed
- Gestational Diabetes Mellitus in Pregnancy
- Life style Intervention
-
Dhaka, Bangladesh
- +19 more
Mar 21, 2021
Biomarker for Wolman Disease (BioWolman)
Active, not recruiting
- Acid Lipase Deficiency
- +2 more
-
Rostock, Germany
- +2 more
May 12, 2021
Biomarker for Patients With Fabry Disease (BioFabry)
Active, not recruiting
- Angiokeratomas
- +3 more
-
Rostock, Germany
- +2 more
May 12, 2021
Biomarker for Krabbe Disease (BioKrabbe)
Active, not recruiting
- Krabbe Disease
-
Cairo, Egypt
- +4 more
May 12, 2021
Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)
Active, not recruiting
- Renal Fanconi Syndrome
- +2 more
-
Rostock, Germany
- +3 more
May 12, 2021
Biomarker for Gilbert Disease (BioGilbert)
Active, not recruiting
- Meulengracht Syndrome
- +2 more
-
Cairo, Egypt
- +3 more
May 12, 2021
Monitoring in Tyrosinemia Type 1 (BioTyrosin)
Active, not recruiting
- Tyrosinosis
- +4 more
-
Rostock, Germany
- +2 more
May 17, 2021
Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
Active, not recruiting
- Hyalinosis
- +4 more
-
Rostock, Germany
- +2 more
May 12, 2021